Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Phase IB Study Investigating the Tolerability, Immunomodulatory Impacts and, Therapeutic Correlates of the Novel Toll-like Receptor 8 Agonist Motolimod (MOTO) Plus Cyclophosphamide (CTX) Treatment of Advanced Solid Tumors

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT02650635
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:37:09.847799+00:00
Published At
2018-09-05T00:00:00+00:00
Record Updated At
2018-09-05
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Colorectal Adenocarcinoma", "Metastatic Pancreatic Adenocarcinoma", "Recurrent Breast Carcinoma", "Recurrent Colorectal Carcinoma", "Recurrent Melanoma of the Skin", "Recurrent Non-Small Cell Lung Carcinoma", "Recurrent Pancreatic Carcinoma", "Recurrent Renal Cell Carcinoma", "Solid Neoplasm", "Stage IV Breast Cancer", "Stage IV Non-Small Cell Lung Cancer", "Stage IV Renal Cell Cancer", "Stage IV Skin Melanoma", "Stage IVA Colorectal Cancer", "Stage IVA Pancreatic Cancer", "Stage IVB Colorectal Cancer", "Stage IVB Pancreatic Cancer"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2018-09-05"
protocolSection.identificationModule.nctId
"NCT02650635"
protocolSection.identificationModule.officialTitle
"Phase IB Study Investigating the Tolerability, Immunomodulatory Impacts and, Therapeutic Correlates of the Novel Toll-like Receptor 8 Agonist Motolimod (MOTO) Plus Cyclophosphamide (CTX) Treatment of Advanced Solid Tumors"
protocolSection.statusModule.overallStatus
"TERMINATED"
protocolSection.designModule.phases
["PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Colorectal Adenocarcinoma (protocolSection.conditionsModule.conditions)
  • Metastatic Pancreatic Adenocarcinoma (protocolSection.conditionsModule.conditions)
  • Recurrent Breast Carcinoma (protocolSection.conditionsModule.conditions)
  • Recurrent Colorectal Carcinoma (protocolSection.conditionsModule.conditions)
  • Recurrent Melanoma of the Skin (protocolSection.conditionsModule.conditions)
  • Recurrent Non-Small Cell Lung Carcinoma (protocolSection.conditionsModule.conditions)
  • Recurrent Pancreatic Carcinoma (protocolSection.conditionsModule.conditions)
  • Recurrent Renal Cell Carcinoma (protocolSection.conditionsModule.conditions)
  • Solid Neoplasm (protocolSection.conditionsModule.conditions)
  • Stage IV Breast Cancer (protocolSection.conditionsModule.conditions)
  • Stage IV Non-Small Cell Lung Cancer (protocolSection.conditionsModule.conditions)
  • Stage IV Renal Cell Cancer (protocolSection.conditionsModule.conditions)
  • Stage IV Skin Melanoma (protocolSection.conditionsModule.conditions)
  • Stage IVA Colorectal Cancer (protocolSection.conditionsModule.conditions)
  • Stage IVA Pancreatic Cancer (protocolSection.conditionsModule.conditions)
  • Stage IVB Colorectal Cancer (protocolSection.conditionsModule.conditions)
  • Stage IVB Pancreatic Cancer (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.